Good science is not necessarily good business
Strong science alone will not get a device to patients. Four insights for medtech founders on aligning clinical need, funding and manufacturing partners early.
-
-
Scrappy is not the same as cheap
Every dollar you spend is a trade-off. A dollar spent on one thing is a dollar that is not available for the next. Some of that money costs ownership. When it does, overspending means founders and early investors give up a bigger share of what they built through dilution. That is why the instinct to…
-
10 MORE mistakes medtech startups make — and how to avoid them
In our previous article, we explored ten common mistakes medtech startups make while developing and commercializing a medical device. This article continues that conversation with mistakes 11 through 20—additional challenges that can create avoidable delays, costs and barriers to adoption. Bringing a medical device to market requires much more than a strong product and a clear clinical need….
-
10 Mistakes medtech startups make — and how to avoid them
Bringing a medical device to market is never just a product challenge. It is a market challenge, a regulatory challenge, a reimbursement challenge, a workflow challenge and ultimately a credibility challenge. Startups that understand this early tend to move faster, waste less capital and build stronger businesses. Startups that do not often find themselves solving…
-
Pathways to Exit: What We Learned at the 2026 MedTech Roadshow
What does it really take to build a medtech company that gets acquired, adopted and valued? Our 2026 MedTech Roadshow brought together founders, investors and industry leaders to explore the decisions that shape a company’s future long before exit — from regulatory and clinical strategy to commercialization, manufacturing and the real drivers of market adoption. With two stops on our 2026 tour: Houston,…
